reference/6542369

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6542369

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural
endingPage	3326
issn	1098-6596 0066-4804
issueIdentifier	9
pageRange	3321-3326
publicationName	Antimicrobial Agents and Chemotherapy
startingPage	3321
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_199db1bef4b0308c0639203aa0befa4f
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_80f2dc668cb89a5556ccde3aeca5bcfe http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e03a7532e83996d1c6ef244aeb34bd7c http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1e23481eb54f16d214db1091e2fe78a6
bibliographicCitation	Vicente E, Villar R, Burguete A, Solano B, Pérez-Silanes S, Aldana I, Maddry JA, Lenaerts AJ, Franzblau SG, Cho S, Monge A, Goldman RC. Efficacy of Quinoxaline-2-Carboxylate 1,4-Di- N -Oxide Derivatives in Experimental Tuberculosis. Antimicrob Agents Chemother. 2008 Sep;52(9):3321–6. doi: 10.1128/aac.00379-08.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f075d82a04de4b643d356e349ae5aea http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_10119dc1191acd73199cbc66ca2e83d7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1545dd3c9f490320836fa0bebce3f14e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_99daeac682052d3db1b4f8a3f64401ab http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_767f055fd469619f5717c5c04048e778 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b4753f1683d29148d552a48c600d316e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8c8b64b14489162ff4c6d6b70be7c04e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_03d51e571e64d2876aa9260e41a0afb9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_23ad5ccc95eb70c366cac1e2ccd897c5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fdc4edc0916f086c87083f77fb5fadde http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d78edf2e9bd8dec0e7882d56c9b86bbb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5d5d310e3909d528eb6b0961251c0f2e
date	200809
identifier	https://doi.org/10.1128/aac.00379-08 https://pubmed.ncbi.nlm.nih.gov/PMC2533452 https://pubmed.ncbi.nlm.nih.gov/18625764
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/686 https://portal.issn.org/resource/ISSN/0066-4804 https://portal.issn.org/resource/ISSN/1098-6596
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Efficacy of Quinoxaline-2-Carboxylate 1,4-Di- N -Oxide Derivatives in Experimental Tuberculosis
discusses	http://id.nlm.nih.gov/mesh/M0001515 http://id.nlm.nih.gov/mesh/M0005453 http://id.nlm.nih.gov/mesh/M0018357
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000995Q000627 http://id.nlm.nih.gov/mesh/D009169Q000187 http://id.nlm.nih.gov/mesh/D003497Q000627 http://id.nlm.nih.gov/mesh/D003497Q000494 http://id.nlm.nih.gov/mesh/D014397Q000188 http://id.nlm.nih.gov/mesh/D000995Q000737 http://id.nlm.nih.gov/mesh/D004195 http://id.nlm.nih.gov/mesh/D011810Q000737 http://id.nlm.nih.gov/mesh/D003497Q000737 http://id.nlm.nih.gov/mesh/D011810Q000627 http://id.nlm.nih.gov/mesh/D011810Q000494 http://id.nlm.nih.gov/mesh/D000995Q000494
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D009169Q000302 http://id.nlm.nih.gov/mesh/D024881 http://id.nlm.nih.gov/mesh/D013047 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D013154Q000382 http://id.nlm.nih.gov/mesh/D013329 http://id.nlm.nih.gov/mesh/D008168Q000382 http://id.nlm.nih.gov/mesh/D014397Q000382 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D008826Q000592 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008810 http://id.nlm.nih.gov/mesh/D000818
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10701 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID456199 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9505 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7045 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4328335 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977

Showing number of triples: 1 to 71 of 71.